AIN457A

BIOLOGICAL3 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Ankylosing SpondylitisChronic Plaque-type PsoriasisPsoriatic Arthritis

Phase 2

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

CompletedNCT00941031

Novartis PharmaceuticalsChronic Plaque-type Psoriasis

Start: 2009-07-31End: 2010-12-31Updated: 2015-08-20

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis

CompletedNCT01109940

Novartis PharmaceuticalsAnkylosing Spondylitis

Start: 2010-04-30End: 2012-12-31Updated: 2021-06-24

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

CompletedNCT01169844

Novartis PharmaceuticalsPsoriatic Arthritis

Start: 2010-06-30End: 2012-11-30Updated: 2021-06-10